OncTox Academy
"Partnering for Smarter and Safer Cancer Care"
Empower healthcare teams to master the use of modern cancer therapies, thereby extending patients' time on treatment while improving their quality of life.
Why Listen to Us?
🔬 Cutting-Edge Therapeutic Focus
Stay ahead of the curve with our in-depth coverage of emerging treatments, including antibody-drug conjugates (ADCs), CAR-T therapy, bispecific T-cell engagers, and immune checkpoint inhibitors and many others.
👥 Expert Multidisciplinary Approach
Our team brings together specialists from various fields to tackle the intricate toxicity profiles of next-generation cancer treatments. This collaborative effort ensures comprehensive, well-rounded insights.
⚡ Practical, Actionable Content
Designed for busy healthcare professionals, our episodes are concise and focused, delivering immediately applicable clinical pearls that you can use right away in your practice.
❤️ Patient-Centered Care
Our strategies are designed to extend patients' time on treatment and improve their quality of life through personalized adverse event management.
Target Audience
- Physicians
- Residents and fellows in-training
- Physician assistants
- Nurse practitioners
- Registered nurses
- Pharmacists
- Healthcare researchers
- Patients, advocates, and caregivers
About Us
At OncTox Academy, we are more than a podcast – we are your partner in navigating the complexities of modern cancer care. Join us as we empower, educate, and inspire you to make every treatment decision count.
Together, we're not just learning about cancer care – we're revolutionizing it, one episode, one insight, one patient at a time. Welcome to the future of oncology education.
Meet Your OncTox Academy Hosts
Dr. Neil J. Shah, MD
Dr. Neil J. Shah is a leading academic medical oncologist whose pioneering work in real-world toxicity management is transforming how clinicians approach next-generation cancer therapies. His research excellence spans modern oncology treatment-related adverse events, data-driven oncology solutions, and clinical outcomes optimization—contributions that have shaped practice standards through publications in premier medical journals.
As a dedicated educator and mentor, Dr. Shah has guided numerous trainees to success, fostering the next generation of oncology leaders. His unique ability to translate complex clinical research into real-world practice, sets him apart in the field.
Through the OncTox Academy Podcast, Dr. Shah delivers expertly crafted, multidisciplinary education that empowers oncology teams to master the art of recognizing, preventing, and managing treatment-related toxicities. His patient-centered approach and evidence-based methodology directly translate to extended treatment duration and enhanced quality of life for patients—making him an indispensable voice in the oncology community.
Dr. Matthew Dallos, MD
Dr. Matthew Dallos is an academic oncologist at the forefront of modern cancer treatment innovation. As a distinguished clinical and translational researcher, he pioneers cutting-edge clinical trials that are reshaping the landscape of immune and targeted therapies across multiple cancer types.
His groundbreaking work has earned him prestigious recognition, including multiple grants and young investigator awards—testament to his commitment to advancing patient care through scientific excellence.
On the OncTox Academy Podcast, Dr. Dallos transforms complex therapeutic concepts into actionable insights, bridging the critical knowledge gap between academic breakthroughs and community practice. His expertise in next-generation cancer therapies and sophisticated toxicity management strategies empowers healthcare professionals worldwide to deliver truly smarter, safer cancer care.
What We Cover
- Treatment insights: Mechanisms, clinical applications, and unique toxicities of emerging therapies.
- Clinical practice: Monitoring and prevention, when to intervene, and dosing optimization.
- Multidisciplinary perspectives: Cardio-oncology, dermatology, GI, endocrine, rheumatology, and supportive care.
- Professional growth: Key takeaways, expert best practices, and case-based learning.
Episodes (Sample Links for Future Episodes)
Episode 1: Introduction to Modern Cancer Therapies
Join Drs. Shah and Dallos as they introduce the OncTox Academy and discuss the evolution of cancer treatment, setting the stage for smarter, safer oncology care.
Episode 2: ADC Toxicity Management
Deep dive into antibody-drug conjugates, exploring their mechanisms, clinical applications, and practical strategies for managing treatment-related adverse events.
Episode 3: CAR-T Cell Therapy Insights
Understanding CAR-T cell therapy complications, monitoring protocols, and multidisciplinary approaches to optimize patient outcomes.
Episode 4: Immune Checkpoint Inhibitors
Exploring the latest developments in immune checkpoint inhibitors, including novel toxicity profiles and evidence-based management strategies.
Our Sponsors
We are grateful to our sponsors who make the OncTox Academy possible. Their support enables us to provide high-quality, evidence-based oncology education to healthcare professionals worldwide.
If you are interested in sponsoring the OncTox Academy and reaching our engaged audience of oncology professionals, please contact us to learn more about partnership opportunities.
Important Disclosures and Terms of Use
Educational Content Disclaimer
The content provided by OncTox Academy, including podcast episodes, materials, and expert contributions, is designed exclusively for educational and informational purposes. This content does not constitute medical advice, diagnosis, or treatment recommendations. Healthcare professionals and patients must always consult with qualified medical practitioners for specific medical conditions, treatment decisions, and patient care.
Professional Relationship Limitations
Participation in OncTox Academy programs, accessing our materials, or engaging with our content does not establish any doctor-patient, healthcare provider-patient, or professional consultation relationship. OncTox Academy, its hosts, contributors, and affiliated institutions assume no duty of care, legal responsibility, or liability for any individual user.
Evolving Medical Knowledge
Oncology and related medical fields are rapidly evolving disciplines with continuous research developments, updated treatment protocols, and emerging therapies. The information presented in our materials reflects the current understanding at the time of publication and may become outdated as new evidence emerges.
Expert Opinions and Independence
Views, analyses, recommendations, and clinical insights expressed by individual contributors, hosts, or guest experts represent their personal professional opinions and do not necessarily reflect the official positions of OncTox Academy, affiliated institutions, or sponsoring organizations. References to specific medications, medical devices, diagnostic tools, or therapeutic products do not constitute endorsements, recommendations, or promotional activities by OncTox Academy. Healthcare professionals must independently evaluate all treatment options, research evidence, and clinical data.
Regulatory Compliance and Off-Label Use
Discussion of therapeutic agents, medical devices, or treatment protocols does not constitute recommendations for off-label, investigational, or non-approved applications. OncTox Academy explicitly disclaims responsibility for any use of treatments, medications, or medical products outside their approved indications, dosing recommendations, or regulatory guidelines. Users must adhere to all applicable regulatory requirements and manufacturer guidelines.
Content Accuracy and Clinical Application
While OncTox Academy maintains high standards for content accuracy and clinical relevance, we provide no warranties or guarantees regarding the completeness, precision, currency, or clinical applicability of any materials. Healthcare professionals must exercise independent clinical judgment, professional expertise, and adherence to established medical protocols when considering any information from our content. Our materials serve as supplementary educational resources and do not supersede institutional guidelines, professional standards of care, or evidence-based treatment protocols.
Digital Platform Security and Privacy
Users acknowledge that digital platforms, including websites, social media channels, podcast platforms, and online communication tools, involve inherent security risks. OncTox Academy disclaims liability for data breaches, unauthorized access, information loss, or privacy violations that may occur through these platforms. Users must never share personally identifiable information (PII), protected health information (PHI), patient data, or confidential medical information through any OncTox Academy platforms or communication channels.
Limitation of Liability
OncTox Academy, its hosts, contributors, sponsors, and affiliated institutions shall not be held liable for any direct, indirect, incidental, consequential, or punitive damages arising from the use of, reliance upon, or inability to access our content and materials.
Acceptance of Terms
By accessing, using, or engaging with OncTox Academy content, users acknowledge that they have read, understood, and agree to be bound by these terms and disclosures.